InvestorsHub Logo
Followers 319
Posts 15903
Boards Moderated 0
Alias Born 01/02/2010

Re: None

Friday, 02/10/2017 10:51:50 AM

Friday, February 10, 2017 10:51:50 AM

Post# of 403076
Significant news IMO. Certainly worthy of more than a penny or two price appreciation.

"“For Cellceutix, there is a lot of activity going on in Texas. Elsewhere, when we mentioned the bioavailability achieved in oral Kevetrin to scientists at our previous Phase 1 clinical site, they commented that it could represent a significant improvement to lengthy or frequent intravenous infusions and urged us to select them as a site for future Kevetrin trials. That is very encouraging, as they are some of the most respected and experienced investigators in the world,” commented Leo Ehrlich, Chief Executive Officer at Cellceutix. “The Company is taking a major step not only toward developing a potent new cancer drug, but one that may become the first ever shown to safely modulate p53, with the added benefit of oral delivery.”

If I recall correctly. The P1 site was MD Anderson. Yep, well respected.
CTIX
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News